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Abstract Multiple studies have reported a male bias in incidence and/or prevalence of malaria
infection in males compared to females. To test the hypothesis that sex-based differences in host-
parasite interactions affect the epidemiology of malaria, we intensively followed Plasmodium
falciparum infections in a cohort in a malaria endemic area of eastern Uganda and estimated both
force of infection (FOI) and rate of clearance using amplicon deep-sequencing. We found no
evidence of differences in behavioral risk factors, incidence of malaria, or FOI by sex. In contrast,
females cleared asymptomatic infections at a faster rate than males (hazard ratio [HR]=1.82, 95% CI
1.20 to 2.75 by clone and HR = 2.07, 95% CI 1.24 to 3.47 by infection event) in multivariate models
adjusted for age, timing of infection onset, and parasite density. These findings implicate biological
sex-based differences as an important factor in the host response to this globally important
pathogen.
Introduction
Malaria, a protozoan infection of the red blood cells, remains one of the greatest global health chal-
lenges (World malaria report, 2019). Infection with malaria parasites results in a wide range of clini-
cal disease presentations, from severe to uncomplicated; in addition, in hyperendemic areas,
asymptomatic infections are common (Bousema et al., 2014). It is well established that chronic
asymptomatic infection with Plasmodium falciparum, the most common and fatal malaria parasite,
can lead to morbidity for those infected and contribute to ongoing transmission (Bousema et al.,
2014; Okell et al., 2012; Tadesse et al., 2018; Slater et al., 2019). Characterization of these
asymptomatic infections is paramount as they represent a major obstacle for malaria elimination
efforts. Therefore, an understanding of how host immunity and parasite factors interact to cause dis-
ease tolerance is required. While age-specific immunity to malaria in hyperendemic areas is well-
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characterized, less attention has been paid to the possibility of a sex bias in malarial susceptibility
despite evidence for a male bias in malaria infections in non-human animals and a male bias in the
prevalence of other human parasitic infections (Zuk and McKean, 1996; Klein, 2004;
Roberts et al., 2001).
The clearest evidence for sexual dimorphism in malaria susceptibility is in pregnant women, who
are at greater risk of malaria infection and also experience more severe disease and higher mortality
(Desai et al., 2007). However, multiple studies performed in different contexts have demonstrated a
male bias in incidence and/or prevalence of malaria infection in school-aged children and adults
(Molineaux et al., 1980; Pathak et al., 2012; Landgraf et al., 1994; Camargo et al., 1996;
Abdalla et al., 2007); this bias is more well established in hypoendemic areas, but has also been
observed in hyperendemic regions (Houngbedji et al., 2015; Mulu et al., 2013). Where there is a
male bias in malaria infection, it has often been postulated that these differences in malaria inci-
dence or prevalence stem from an increased risk of males acquiring infection due to socio-behavioral
factors (Pathak et al., 2012; Camargo et al., 1996; Moon and Cho, 2001; Finda et al., 2019). How-
ever, because biological sex itself has been demonstrated to affect responses to other pathogens,
an alternative hypothesis is that the sexes may have different responses to the malaria parasite once
infected (Nhamoyebonde and Leslie, 2014; Bernin and Lotter, 2014; Fischer et al., 2015;
Fish, 2008).
Estimating the host response to P. falciparum infection requires close follow-up of infected indi-
viduals, sensitive detection of parasites, and the ability to distinguish superinfection, which is com-
mon in endemic areas, from persistent infection. To test the hypothesis that sex-based differences in
host–parasite interactions affect the epidemiology of malaria, we intensively followed a representa-
tive cohort of individuals living in a malaria endemic area of eastern Uganda. Using frequent sam-
pling, ultrasensitive quantitative PCR (qPCR), and amplicon deep-sequencing to genotype parasite
clones, we were able to accurately detect the onset of new infections and follow all infections over
time to estimate their duration. Using these data, we show that females cleared their asymptomatic
infections more rapidly than males, implicating biological sex-based differences as important in the
host response to this globally important pathogen.
Results
Cohort participants and P. falciparum infections
This analysis involved data from 477 children and adults (233 males and 244 females) that were fol-
lowed for a total of 669.6 person-years (Table 1). 25 participants, 10 males and 15 females, were
enrolled after initial enrollment (Figure 1); median duration of follow-up in those who were dynami-
cally enrolled was 0.84 years (IQR 0.69–1.23) compared to 1.45 years (IQR 1.43–1.47) in those
enrolled during initial enrollment. 149 of 477 participants (31.2%) included in the analysis had at least
one P. falciparum infection detected (Figure 1). 114 participants had 822 successfully genotyped
samples and had infections characterized by clone and by infection event. 35 samples (from 35
unique participants) had very low-density infections (<1 parasite/mL) that could not be genotyped;
these infections were characterized at the infection event level only. We achieved a read count
of >10,000 for 92% of genotyped samples, identifying 45 unique AMA-1 clones in our population
(frequencies and sequences in Supplementary file 1e). At the clone level, the proportion of baseline
infections out of all infections in males was 117/171 (68.4%), compared to 68/116 (58.8%) baseline
infections in females (p=0.10). At the infection event level, there were 54/104 (51.9%) baseline infec-
tions in males and 45/89 (50.6%) baseline infections in females (p=0.89).
Behavioral malaria risk factors and measures of malaria burden
There was no difference in reported rates of LLIN use the previous night by sex (Table 1). Women
over the age of 16 traveled overnight outside of the study area more than men (incidence rate ratio
[IRR] for females vs. males = 3.61, 95% confidence interval [CI] 1.83 to 7.13), a potential risk factor
for malaria exposure. Antimalarial use outside the study clinic was reported only four times (3
females and one male, all under the age of 5). In this region receiving regular rounds of IRS, the inci-
dence of symptomatic malaria was low in all age categories, and there was no evidence of a differ-
ence in incidence of symptomatic malaria by sex overall (IRR for females vs. males = 1.11, 95% CI
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Table 1. Behavioral risk factors for malaria infection and measures of malaria burden in study population, stratified by age and sex.
Metric
Age and gender categories
All <5 years old 5–15 years old 16 years and older
Male Female Male Female Male Female Male Female
Number of participants, n 233 244 73 84 101 71 59 89
Median days of follow-up per participant 530.0 530.0 525.0 524.5 530.0 531.0 530.0 530.0
Slept under LLIN the previous night 53.6% 56.3% 54.1% 56.3% 47.9% 47.8% 63.7% 64.3%
Person-years of follow-up 324.2 345.4 87.3 96.7 152.6 118.5 84.22 130.1
Number of overnight trips 44 107 21 19 9 10 14 78
Incidence of overnight trips*, (95% CI) 0.14
(0.09–0.20)
0.31
(0.20–0.49)
0.24
(0.14–0.42)
0.20
(0.09–0.42)
0.06
(0.03–0.13)
0.08
(0.03–0.24)
0.17
(0.09–0.31)
0.60
(0.30–1.18)
Episodes of malaria* 11 13 5 2 5 9 1 2
Incidence of malaria**, (95% CI) 0.03
(0.02–0.06)
0.04
(0.02–0.09)
0.06
(0.02—0.16)
0.02
(0.00–0.11)
0.03
(0.01–0.08)
0.08
(0.03–0.23)
0.01
(0.00–0.08)
0.02
(0.00–0.17)
Number of routine visits, n 4316 4583 1164 1293 2034 1568 1118 1722
Prevalence of microscopic parasitemia*** 2.9% 1.4% 1.8% 1.1% 4.4% 2.7% 1.3% 0.5%
Prevalence of parasitemia by qPCR 14.4% 9.2% 5.8% 3.7% 17.0% 15.3% 18.5% 7.7%
Geometric mean parasite density**** 3.41 3.06 4.86 13.06 6.31 4.20 1.09 1.02
Median complexity of infection, (IQR) 3 (1–7) 2 (1–2) 1 (1–2.5) 2 (1–2.3) 4 (2–9) 2 (1–2) 1 (1–2) 1 (1–2)
*Malaria includes one episode (female,<5 years old), due to non-falciparum species (P. malariae).
**per person-year.
***Parasitemia by light microscopy includes one episode (female, 5–15 years old) due to non-falciparum species (P. ovale).
****Geometric mean parasite density in parasites/mL of all qPCR-positive routine visits.
509 participants enrolled between October 1st, 2017 and March 31st, 2019 
477 participants included in primary analyses 
452 enrolled during initial enrollment (October 1st, 2017 through October 31st, 2017) 
25 enrolled during dynamic phase 
 
32 excluded for < 6 months of follow-up 
  
P. falciparum infections   
149 participants with at least one positive qPCR result 
       35 with low density infections unable to be genotyped 
 
Infection event-level data  
193 infections in 149 people 
 99 baseline infections 
94 new infections 
Clone-level data 
287 infections in 114 people 
185 baseline infections 
102 new infections 
 
114 participants with at least one genotyped infection 
822 genotyped samples 
 
Figure 1. Study design.
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0.49 to 2.52) or when adjusted for age (IRR = 1.26, 95% CI 0.54 to 2.96). In contrast, prevalence ratio
(PR) of P. falciparum parasitemia by microscopy in females versus males across all age categories
was 0.49 (95% CI 0.36 to 0.65), with relative differences in prevalence most pronounced in the oldest
age group. Similar findings were seen when prevalence was assessed by ultrasensitive qPCR, with
PR = 0.64 in females vs. males (95% CI 0.43 to 0.96), again with the largest differences seen in the
oldest age group. Adjusting for age as a categorical variable, LLIN use, and travel did not qualita-
tively change prevalence ratios for microscopic parasitemia (PR in females vs. males = 0.57, 95% CI
0.42 to 0.77) or for qPCR-positive parasitemia (PR in females vs. males = 0.67, 95% CI 0.60 to 0.76).
We also found no evidence for a difference in parasite density as determined by qPCR between
males and females after adjusting for age as a continuous variable (p=0.47). Median complexity of
infection (COI) was higher in males than in females overall, driven primarily by a higher COI in male
school-aged children.
Force of infection by age and sex
To determine whether higher infection prevalence in males was due to an increased rate of infection,
we used longitudinal genotyping to calculate the force of infection (FOI, number of new blood stage
infections per unit time). Overall, the FOI was low, with new infections occurring on average less
than once every 5 years (Table 2). There was no evidence for a significant difference in FOI by sex
overall (IRR for females vs. males = 0.88, 95% CI 0.48 to 1.62 by clone and IRR = 0.83, 95% CI 0.52
to 1.33 by infection event). There was also no evidence for a significant difference in FOI by sex
when adjusted for age category (IRR = 0.88, 95% CI 0.47 to 1.63 by clone and IRR = 0.83, 95% CI
0.53 to 1.31 by infection event). For analysis both by clone and by infection event, there was a trend
toward higher FOI in males compared to females. We performed a sensitivity analysis by decreasing
the number of skips necessary to declare an infection cleared (Supplementary file 1f). Performing
the same analysis using one skip for clearance instead of 3 skips increased the FOI in all groups and
increased the trend toward higher FOI in males, with IRR for females vs. males when adjusted for
age category = 0.71, 95% CI 0.41 to 1.24 by clone and IRR = 0.75, 95% CI 0.47 to 1.22 by infection
event.
Rate of clearance of infection and duration of infection by sex
Since females had a lower prevalence of infection but similar rate of acquiring infections compared
to males, we evaluated whether there was a difference between sexes in the rate at which infections
were cleared. Asymptomatic infections were included in this analysis if they were not censored as
stated in the methods. At the clone level, 105 baseline infections and 53 new infections were
included; there was a slightly higher proportion of baseline infections in males (68/99, 68.7%), com-
pared to the proportion of baseline infections in females (37/59, 62.7%) (p=0.49). At the infection
event level, 58 baseline infections and 51 new infections were included and there was no difference
in the proportion of baseline infections by sex, with 32/60 (53.3%) baseline infections in males and
26/49 (53.1%) baseline infections in females (p=1.0).
Unadjusted hazard ratios for clearing infecting clones showed that asymptomatic infections
cleared naturally (i.e., when not treated by antimalarials) at nearly twice the rate in females vs. males
(hazard ratio (HR) 1.92, 95% CI 1.19 to 3.11, Table 3). In addition, new infections cleared faster than
Table 2. Molecular force of infection (FOI) by clone and by infection event, stratified by age and sex.
Molecular force of infection (FOI) Sex
Age category
All <5 years 5–15 years 16 years or older
By clone, ppy* (95% CI) All 0.18 (0.13–0.24) 0.14 (0.07–0.28) 0.19 (0.08–0.43) 0.20 (0.08–0.46)
Male 0.19 (0.12–0.30) 0.16 (0.07–0.39) 0.19 (0.10–0.37) 0.22 (0.09–0.54)
Female 0.17 (0.09–0.31) 0.12 (0.03–0.49) 0.19 (0.08–0.45) 0.18 (0.06–0.54)
By event, ppy* (95% CI) All 0.14 (0.11–0.18) 0.09 (0.06–0.16) 0.16 (0.09–0.30) 0.16 (0.08–0.32)
Male 0.16 (0.11–0.22) 0.13 (0.07–0.27) 0.18 (0.11–0.28) 0.15 (0.07–0.29)
Female 0.13 (0.08–0.21) 0.06 (0.02–0.18) 0.14 (0.07–0.27) 0.17 (0.07–0.41)
*per person-year.
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baseline infections and monoclonal infections cleared faster than polyclonal infections. Unadjusted
hazard ratios for clearance of infection events (as opposed to clones) also showed faster clearance in
females vs. males (HR = 2.30, 95% CI 1.20 to 4.42). Results were similar in multivariate models
including age, gender, the period during which the infection was first observed, and parasite den-
sity, demonstrating faster clearance in females vs. males (HR = 1.82, 95% CI 1.20 to 2.75 by clone
and HR = 2.07, 95% CI 1.24 to 3.47 by infection event). Complexity of infection was not included in
the final adjusted model because the model fit the data less well when COI was included as a predic-
tor. In both adjusted models, new infections cleared faster than baseline infections. Higher parasite
densities were associated with slower clearance by clone and by infection event, but the effect size
was larger when data were analyzed by infection event (HR = 0.44, 95% CI 0.35 to 0.54). There was
no evidence for interaction between age and sex in either adjusted model. We performed a sensitiv-
ity analysis by decreasing the number of skips necessary to declare an infection cleared. Regardless
of whether three skips, two skips, or one skip was used to determine infection clearance, females
cleared their infections faster than males both by clone and by infection event (Supplementary file
1g).
We next estimated durations of asymptomatic infection by age and sex using results from a
model that included these covariates (Figure 2). Durations of infection ranged from 103 days to 447
days by clone, and from 87 to 536 days by infection event. Males had a longer duration of infection
across all age categories. Children aged 5–15 years had the longest duration of infection, followed
by adults. Therefore, overall, males aged 5–15 years had the longest estimated duration of infection
by either clone (447 days) or infection event (526 days).
Discussion
Previous studies have reported a higher prevalence of malaria infection in males compared to
females, with the difference often ascribed to differences in exposure (Molineaux et al., 1980;
Pathak et al., 2012; Landgraf et al., 1994; Camargo et al., 1996; Abdalla et al., 2007;
Houngbedji et al., 2015; Mulu et al., 2013). In a cohort study in eastern Uganda, we noted higher
prevalence of malaria infection in males compared to females. By closely following a cohort of chil-
dren and adults and genotyping every detected infection with sensitive amplicon deep-sequencing,
we were able to estimate both the rate of infection (FOI) and duration of infection and to compare
these measures by sex. We found that lower prevalence in females did not appear to be due to
lower rates of infection but rather due to faster clearance of asymptomatic infections. To our knowl-
edge, this is the first study to report a sex-based difference in the duration of malaria infection.
Though there are some conflicting reports in the literature, the majority of studies of malaria inci-
dence and/or prevalence that evaluated associations with sex in late childhood, adolescence and
Table 3. Hazard ratios for rates of clearance of infection, by clone and by infection event.
Predictors Categories
Hazard ratio by clone (95% CI)
Hazard ratio by infection event (95%
CI)
Unadjusted Adjusted Unadjusted Adjusted
Sex Male ref ref ref ref
Female 1.92 (1.19–3.11) 1.82 (1.20–2.75) 2.30 (1.20–4.42) 2.07 (1.24–3.47)
Age 16 years or greater ref ref ref ref
5–15 years 0.66 (0.39–1.10) 0.81 (0.49–1.36) 0.82 (0.39–1.74) 1.27 (0.72–2.25)
<5 years 1.64 (0.79–3.41) 1.55 (0.76–3.17) 2.01 (0.80–5.00) 1.75 (0.87–3.53)
Complexity of infection (COI) Polyclonal (COI > 1) ref – ref –
Monoclonal (COI = 1) 1.63 (1.03–2.57) – 0.95 (0.38–2.34) –
Infection status Present at baseline ref ref ref ref
New infection 1.94 (1.22–3.07) 1.75 (1.05–2.94) 4.66 (2.58–8.42) 4.32 (2.59–7.20)
Parasite density * 0.85 (0.69–1.06) 0.81 (0.65–1.00) 0.41 (0.32–0.51) 0.44 (0.35–0.54)
*Increasing parasite density (log10) in parasites/microliter, as measured by qPCR.
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adulthood have found a male bias in the observed measure of burden (Molineaux et al., 1980;
Pathak et al., 2012; Landgraf et al., 1994; Camargo et al., 1996; Abdalla et al., 2007;
Houngbedji et al., 2015; Mulu et al., 2013). We note that this is more often observed in hypoen-
demic settings and may be confounded by factors such as treatment-seeking behavior; however, this
male bias has been reported in studies of both P. vivax and P. falciparum. Overall, these studies con-
sistently suggest that males exhibit higher incidence and/or prevalence of malaria that begins during
late childhood, persisting through puberty and the majority of adulthood (excepting the years when
pregnancy puts women at higher risk). One possible explanation put forward for the sex-specific dif-
ference in burden has been that males are more frequently bitten by malaria-carrying mosquitos due
to behavioral differences such as working outside, not sleeping under a net, or traveling for work
(Pathak et al., 2012; Camargo et al., 1996; Moon and Cho, 2001; Finda et al., 2019). In our study,
however, there were no statistically significant differences in malaria incidence or FOI by sex, though
there was a trend toward higher FOI in males. We also saw no evidence of behavioral trends that
would result in more infections in males; in fact, older women in our study did most of the traveling
outside the study area (an area of low transmission compared to surrounding areas). We did not
assess work habits as part of our study questionnaire, but the fact that we observe similar patterns in
prevalence by sex in all age categories makes this a less likely explanation. Therefore, in this particu-
lar cohort, it appears that the observed male bias in parasite prevalence is best explained by slower
clearance of infection in males. We cannot rule out that males were differentially exposed in the
recent past (e.g., had a higher force of infection when transmission was higher, which could have
affected immunity), and we plan to genotype samples from a prior cohort from 2011 to 2017 to test
this hypothesis.
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Figure 2. Estimates of duration of infection from sex- and age-adjusted model. Estimated duration of infection in
days, calculated by adjusting the point estimate of the baseline hazard by the coefficients of the sex- and age-
adjusted model. Error bars represent standard errors of duration obtained from variance in the model coefficients.
Point estimates of duration are labeled (*).
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Very few studies have been conducted to explore immunological differences between males and
females in their response to the malaria parasite. RTS,S vaccination is associated with higher all-
cause mortality in girls compared to boys, and a trend toward higher risk of fatal malaria has been
noted in vaccinated girls compared to boys, suggesting possible sexual dimorphism in immunologi-
cal responses to malaria (Klein et al., 2016). The comprehensive Garki project found a male bias in
the prevalence of P. falciparum infection after the age of 5 years that was noted to increase after
control measures including IRS and mass drug administration. They also found that females had
higher levels of certain antibodies against P. falciparum compared to males, but saw no difference in
these levels after control measures (Molineaux et al., 1980). Hormonal differences have been pos-
ited to play a role in these sex-based immunological differences to malaria infection; for example,
studies in mice show that testosterone appears to downregulate the immune response to malaria
(Delić et al., 2011; Wunderlich et al., 1991). One study of irradiated sporozoite vaccination in mice
showed that female mice vaccinated after puberty were better protected than males following para-
site challenge, but this sex difference was not seen if the mice were vaccinated prior to puberty, sug-
gesting a role for sex hormones in the development of immunity (Vom Steeg et al., 2019).
Testosterone was again associated with decreased protection from malaria in that study
(Vom Steeg et al., 2019). In addition, in Kenya, two studies showed that dehydroepiandrosterone
sulfate (DHEAS) levels were significantly associated with decreased parasite density in both males
and females, even after adjustment for age, but neither study directly compared males to females
(Kurtis et al., 2001; Leenstra et al., 2003). Given that levels and types of sex hormones differ
between males and females, as does the age of onset of puberty, the interaction between these hor-
mones, age, and protection against malaria is likely to be complicated. We did not detect an interac-
tion between age and sex in our model. This could be due to a lack of statistical power or imperfect
detectability, as adults have lower density infections than children due to improved anti-parasite
immunity (Bousema et al., 2014; Okell et al., 2012). In addition, the adult age group was com-
prised of a wide age range, which included post-menopausal women and might have blunted the
effect of sex in that age group if there is a hormonal basis for some of this effect. Repeating our
analysis using different age categories (<8 years, 8–13 years, and 13+ years) did not significantly
change our findings. It is also possible that sex-based differences are explained by a different mech-
anism, such as differences in innate immunity, Y-linked chromosomal factors in males, increased
X-linked gene expression in females, or by a combination of factors. More studies are needed to elu-
cidate the relationship between sex-based biological differences between males and females and
their impact on the development of effective antimalarial immunity in humans.
Of the variables we evaluated in addition to sex, baseline infection status and parasite density
were most strongly associated with the rate of clearance of infection. Infections that were already
present at the beginning of the study and persisted past the left censoring date may have been a
non-random selection of well-established asymptomatic infections that were present at baseline at a
higher frequency than average because they had a fundamentally different trajectory than newly
established asymptomatic infections. Higher parasite densities were also associated with slower
clearance of infection in both adjusted models, but the effect was most pronounced when the data
were analyzed by infection event. This may be because low-density infections that we were unable
to successfully genotype were only included in the infection event analysis, and these events tended
to have short durations. The inclusion of parasite density in our multivariate models did not meaning-
fully alter associations between sex and duration of infection, providing evidence that the sex-based
differences in duration were not mediated primarily by differences in parasite density in our cohort.
A limitation of our study is the statistical model’s assumption that all infections clear at the same
rate, which was necessary because we did not observe the beginning of most infections. To rely less
on this assumption, we adjusted for baseline infections, allowing them to have a different rate of
clearance than new infections; this did not change our primary finding of a difference in rate of clear-
ance by sex. We also acknowledge there may be other unmeasured confounders, such as genetic
hemoglobinopathies or sex-based differences in unreported outside antimalarial use, that could
affect our results. Another caveat is that our findings may not be generalizable to areas with differ-
ent transmission intensity given that our study was conducted in a very specific setting: an area with
previously very high transmission intensity that has been greatly reduced in recent years by repeated
rounds of IRS.
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Additionally, because it is difficult to genotype low-density infections and because parasite densi-
ties fluctuate over time, we allowed several ‘skips’ in detection before declaring an infection cleared
or the same clone in an individual a new infection with the same clone. This requires the assumption
that re-infection with the same clone is relatively rare, which is reasonable given the high genetic
diversity and low force of infection seen in this setting; this assumption has been made in other lon-
gitudinal genotyping studies (Felger et al., 2012; Smith et al., 1999). Our method may have biased
us toward longer durations of infection and fewer new infections overall, but this is unlikely to have
introduced any significant bias in the observed associations by sex. We performed a sensitivity analy-
sis to ensure that changing the number of skips allowed did not significantly change the main finding
regarding longer duration of infection in males and our findings were consistent. Given decreasing
parasite densities over time and a setting with low force of infection and low EIR, assuming perfect
recovery of clones is likely to artificially inflate the force of infection in this cohort. There were not
enough infections to perform a rigorous analysis of the distribution of clones within and between
households, but given that the overall force of infection was quite low, the probability of re-infection
with the same clone already present in a participant from another member in the household (which
could bias toward longer duration of infection) was low and unlikely to have introduced any signifi-
cant bias by sex.
In summary, we estimated the clearance of asymptomatic P. falciparum infections by genotyping
longitudinal samples from a cohort in Nagongera, Uganda, using sensitive amplicon deep-sequenc-
ing and found that females cleared their infections at a faster rate than males; this finding remained
consistent when adjusting for age, baseline infection status, and parasite density. Furthermore, we
found no conclusive evidence for a sex-based difference in exposure to infection, either behaviorally
or by FOI. Though there have long been observed differences in malaria burden between the sexes,
there is still little known about sex-based biological differences that may mediate immunity to
malaria. Unfortunately, much reported malaria data is still sex-disaggregated. Our findings should
encourage epidemiologists to better characterize sexual dimorphism in malaria and motivate
increased research into biological explanations for sex-based differences in the host response to the
malaria parasite.
Materials and methods
Study setting and population-level malaria control interventions
This cohort study was carried out in Nagongera sub-county, Tororo district, eastern Uganda, an area
with historically high malaria transmission. However, 7 rounds of indoor residual spraying (IRS) from
2014 to 2019 have resulted in a significant decline in the burden of malaria (Nankabirwa et al.,
2019). Pre-IRS, the daily human biting rate (HBR) was 34.3 and the annual entomological inoculation
rate (EIR) was 238; after 5 years of IRS, in 2019 the daily HBR was 2.07 and overall annual EIR was
0.43 as reported by Nankabirwa et. al (Nankabirwa et al., 2020).
Study design, enrollment, and follow-up
All members of 80 randomly selected households with at least two children were enrolled in October
2017 using a list generated by enumerating and mapping all households in Nagongera sub-county
(Nankabirwa et al., 2020). The cohort was dynamic such that residents joining the household were
enrolled and residents leaving the household were withdrawn. Data for this analysis was collected
from October 1st, 2017 through March 31st, 2019; participants were included if they had at least 6
months of contiguous follow-up. Data from the 25 dynamically enrolled participants contributed to
all analyses, including that of baseline infections. Participants were followed at a designated study
clinic open daily from 8 AM to 5 PM. Participants were encouraged to seek all medical care at the
study clinic and avoid the use of antimalarial medications outside of the study. Routine visits were
conducted every 28 days and included a standardized clinical evaluation, assessment of overnight
travel outside of Nagongera sub-county, and collection of blood by phlebotomy for detection of
malaria parasites by microscopy and molecular studies. Participants came in for non-routine visits in
the setting of illness. Blood smears were performed at enrollment, at all routine visits and at non-
routine visits if the participant presented with fever or history of fever in the previous 24 hr. Partici-
pants with fever (>38.0˚C tympanic) or history of fever in the previous 24 hr had a thick blood smear
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read urgently. If the smear was positive, the patient was diagnosed with malaria and treated with
artemether-lumefantrine. Participants with asymptomatic parasitemia as detected by qPCR or
microscopy were not treated with antimalarials, consistent with Uganda national guidelines. Study
participants were visited at home every 2 weeks to assess use of long-lasting insecticidal nets (LLINs)
the previous night.
Laboratory methods
Thick blood smears were stained with 2% Giemsa for 30 min and evaluated for the presence of asex-
ual parasites and gametocytes. Parasite densities were calculated by counting the number of asexual
parasites per 200 leukocytes (or per 500, if the count was less than 10 parasites per 200 leukocytes),
assuming a leukocyte count of 8,000/mL. A thick blood smear was considered negative if examina-
tion of 100 high power fields revealed no asexual parasites. For quality control, all slides were read
by a second microscopist, and a third reviewer settled any discrepant readings. In our experienced
microscopists’ hands, the lower limit of detection is approximately 20–50 parasites/mL.
For qPCR and genotyping, we collected 200 mL of blood at enrollment, at each routine visit, and
at the time of malaria diagnosis. DNA was extracted using the PureLink Genomic DNA Mini Kit (Invi-
trogen) and parasitemia was quantified using an ultrasensitive varATS qPCR assay with a lower limit
of detection of 0.05 parasites/mL (Hofmann et al., 2015). Samples with a parasite density >= 0.1
parasites/mL blood were genotyped via amplicon deep-sequencing. All samples positive for asexual
parasites by microscopy but negative for P. falciparum by qPCR were tested for the presence of
non-falciparum species using nested PCR (Snounou et al., 1993).
Sequencing library preparation
Hemi-nested PCR was used to amplify a 236 base-pair segment of apical membrane antigen 1
(AMA-1) using a published protocol (Miller et al., 2017), with modifications (Supplementary file
1a). Samples were amplified in duplicate, indexed, pooled, and purified by bead cleaning. Sequenc-
ing was performed on an Illumina MiSeq platform (250 bp paired-end).
Bioinformatics methods
Data extraction, processing, and haplotype clustering were performed using SeekDeep
(Hathaway et al., 2018), followed by additional filtering (Lerch et al., 2019). Supplementary file
1b shows the full bioinformatics workflow.
Data analysis
A clone was defined as a genetically identical group of parasites, for example with identical haplo-
types. Because polyclonal infections can occur due to co-infection (one mosquito bite transmitting
multiple clones) or superinfection (multiple bites), we analyzed the infection data both by clone and
by infection event. For analysis by clone, each unique clone was counted as an infection and each
clone’s disappearance as a clearance event. For analysis by infection event, any new clones seen
within 3 visits of the date of the first newly detected clone(s) were grouped together and considered
one new ‘infection event.’ Clearance of infection for these events required that all clones in the
group be absent. A baseline infection was defined as a clone or infection event (group of clones)
detected in the first 60 days of observation of a participant. New infections were defined as a new
clone or infection event (group of clones) detected in a participant after day 60.
Imperfect detection of P. falciparum clones is known to be a limitation of all PCR-based genotyp-
ing methods; both biological factors, such as deep organ sequestration of clones in the lifecycle of
the parasite, and methodological factors, such as difficulty amplifying minority clones (especially at
lower parasite densities), results in imperfect detectability of all clones present in a single blood sam-
ple drawn on a single day (Felger et al., 2012; Koepfli and Mueller, 2017; Nguyen et al., 2018;
Koepfli et al., 2011; Ross et al., 2012). Though amplicon deep-sequencing is less likely than other
methods to miss minority clones (Lerch et al., 2017), detectability was a particular concern in our
study, in which the majority of infections were submicroscopic and parasite densities declined over
time [Supplementary file 1c]. To account for the fact that a clone might be missed in a single sam-
ple due to fluctuations in parasite density and/or methodological limitations, we allowed 3 ‘skips’ in
detection and classified an infection as cleared only if it was not identified in four contiguous
Briggs et al. eLife 2020;9:e59872. DOI: https://doi.org/10.7554/eLife.59872 9 of 14
Research article Epidemiology and Global Health Microbiology and Infectious Disease
samples from routine visits. If the infection (as determined by clone or by infection event) was absent
for four routine samples in a row, the last date of detection would be the end date of that infection.
Therefore, for a clone that had previously infected an individual to be classified as a new infection, it
had to have been absent from that individual for at least four routine visits. Additional details are
found in Supplementary file 1d. This decision was supported by the fact that the diversity of the
genotyped AMA-1 amplicon was quite high (expected heterozygosity = 0.949), resulting in a low
probability (5.1%) for infection with the same clone by chance.
Data analysis was conducted in R (R Development Core Team, 2019) and Python
(Python Language Reference, 2020). Travel was self-reported at routine visits, and LLIN use on the
previous night was reported by field entomology teams who surveyed households every two weeks.
Microscopic parasite prevalence was defined by the number of smear-positive routine visits over all
routine visits. Parasite prevalence by qPCR was defined as the number of qPCR-positive visits over
all routine visits. Thus, these measures represent the average prevalence during routine visits. Preva-
lence ratios were computed using Poisson regression with generalized estimating equations to
adjust for repeated measures. Comparison of parasite density by sex was made using linear regres-
sion with generalized estimating equations to adjust for repeated measures. Force of infection (FOI)
was defined as the number of new infections, including malaria episodes, divided by person time.
Since the start of baseline infections was not observed, baseline infections were not included in cal-
culating FOI. Poisson regression with generalized estimating equations to account for repeated
measures was used to estimate malaria incidence, FOI, and to calculate incident rate ratios (IRR) for
malaria and FOI. Hazards for clearance of untreated, asymptomatic infections were estimated using
time-to-event models (shared frailty models fit using R package ‘frailtypack,’ version 2.12.2)
(Rondeau and Gonzalez, 2005; Rondeau et al., 2012). Infections were censored for this analysis if
they were only observed in the first three months or the last three months (before January 01, 2018
and after January 01, 2019) because they were not observed for long enough to determine whether
clearance occurred. If an infection was observed for only one timepoint, it was assigned a duration
of 14 days. These models assumed a constant hazard of clearance and included random effects to
account for repeated measures in individuals. Parasite density was included in the model as a time-
varying covariate. Duration of infection in days was calculated as 1/adjusted hazard.
Data accessibility
Data from the cohort study is available through an open-access clinical epidemiology database
resource, ClinEpiDB at https://clinepidb.org/ce/app/record/dataset/DS_51b40fe2e2. Genotyping
data and code used to generate tables and figures is available on GitHub (Briggs, 2020; copy
archived at swh:1:rev:cf6c3256e609f4f136fc8d90f9cae1d61d6d8d63).
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